Advanced search
Publication Cover
Future Oncology Volume 6, 2010 - Issue 9
Submit an article Journal homepage
863
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Long-Term Cardiovascular Risk Following Platinum-Based Chemotherapy for Germ Cell Tumors

Clary Evans1 Department of Oncology, Addenbrooke’s Hospital, Hill’s Road, CambridgeCB2 0QQ, UK. [email protected]View further author information
,
Michael Williams1 Department of Oncology, Addenbrooke’s Hospital, Hill’s Road, CambridgeCB2 0QQ, UK. [email protected]View further author information
&
Danish Mazhar1 Department of Oncology, Addenbrooke’s Hospital, Hill’s Road, CambridgeCB2 0QQ, UK. [email protected]Correspondence[email protected]
View further author information
Pages 1365-1368 | Published online: 04 Oct 2010

Bibliography

  • Vogelzang NJ , BoselGJ, JohnsonKet al.: Raynaud’s phenomenon: a common toxicity after combination chemotherapy for testicular cancer.Ann. Intern. Med.95, 288–292 (1981).
  • Meinardi MT , GietemaJA, van der GrafWTet al.: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.J. Clin. Oncol.18, 1725–1732 (2000).
  • Huddart RA , NormanA, ShahidiMet al.: Cardiovascular disease as a long-term complication of treatment for testicular cancer.J. Clin. Oncol.21, 1513–1523 (2003).
  • van den Belt-Dusebout AW , NuverJ, de WitRet al.: Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.J. Clin. Oncol.24, 467–475 (2006).
  • Powles T , RobinsonD, ShamashJ, MollerH, TranterN, OliverT: The long-term risks of adjuvant carboplatin treatment for stage 1 seminoma of the testis.Ann. Oncol.19, 443–447 (2008).
  • Van den Belt-Dusebout AW , de WitR, GietemaJAet al.: Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.J. Clin. Oncol.25, 4370–4378 (2007).
  • Gietema JA , MeinardiMT, MesserschmidtJet al.: Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.Lancet355, 1075–1076 (2000).
  • Vaughn DJ , PalmerSC, CarverJRet al.: Cardiovascular risk in long-term survivors of testicular cancer.Cancer112, 1949–1953 (2008).
  • Alterna R , de HassEC, NuverJet al.: Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.Br. J. Cancer100, 1861–1866 (2009).
  • Sagstuen H , AassN, FossaSDet al.: Blood pressure and body mass index in long-term survivors of testicular cancer.J. Clin. Oncol.23, 4980–4990 (2005).
  • Bokemeyer C , BergerCC, KuczykMAet al.: Evaluation of long-term toxicity after chemotherapy for testicular cancer.J. Clin. Oncol.14, 2923–2932 (1996).
  • Gietema JA , SieijferDT, WillemsePHet al.: Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer.Ann. Intern. Med.116(9), 709–715 (1992).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.